These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38268737)

  • 1. Dural involvement in central nervous system langerhans cells histiocytosis (LCH) on FDG PET/CT: Case report and review of CNS manifestations of LCH on PET/CT.
    Eddin AS; McNeely P; Saad Eldine M; Lai L; Shariftabrizi A
    Radiol Case Rep; 2024 Apr; 19(4):1391-1396. PubMed ID: 38268737
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive considerations for dermatologists: the application of FDG-PET in evaluating cutaneous lesions in pediatric Langerhans cell histiocytosis.
    Talasila S; Teichner EM; Subtirelu RC; Talasila NCP; Mannam S; Werner T; Alavi A; Revheim ME
    Front Med (Lausanne); 2024; 11():1378638. PubMed ID: 39071084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of
    Liao F; Luo Z; Huang Z; Xu R; Qi W; Shao M; Lei P; Fan B
    Contrast Media Mol Imaging; 2022; 2022():8385332. PubMed ID: 36051931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
    Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET-CT in pediatric Langerhans cell histiocytosis.
    Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Garcia JR; Riera E; Bassa P; Mourelo S; Soler M
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):325-328. PubMed ID: 28262495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
    Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
    Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of
    Luo ZH; Lu PX; Qi WL; Liao FX; Jin AF; Zen QY
    Quant Imaging Med Surg; 2022 Jun; 12(6):3351-3363. PubMed ID: 35655814
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Shamim SA; Tripathy S; Mukherjee A; Bal C; Tripathi M
    Indian J Nucl Med; 2017; 32(2):162-163. PubMed ID: 28533655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
    Lee HJ; Ahn BC; Lee SW; Lee J
    Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
    An R; Ma X; Wang Y
    Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging
    Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle Infiltrative Adult Multisystem Langerhans Cell Histiocytosis Detected on Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography - A Rare Case.
    Rayamajhi SJ; Shahi RR; Maharjan S; Sharma S; Sudhir Suman KC
    Indian J Nucl Med; 2020; 35(4):342-344. PubMed ID: 33642763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of whole-body DW-MRI with 2-[
    Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
    Phillips M; Allen C; Gerson P; McClain K
    Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Niu J; Liang J; Feng Q; Wang M; Wang L; Ge X; Wang X; Ding Z
    Int J Gen Med; 2021; 14():6251-6259. PubMed ID: 34629891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated Scapular Lesion of Langerhans Cell Histiocytosis Detected by
    Filizoğlu N; Özgüven S; Türköz HK; Öneş T; Turoğlu HT; Erdil TY
    Mol Imaging Radionucl Ther; 2022 Oct; 31(3):237-238. PubMed ID: 36268929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.